Additional Educational Resources

You may have questions about insurance coverage. Read the information below to learn more

My co-pay for DATROWAY is too high. How can you help me?

The DATROWAY Patient Savings Program is available for commercially insured patients. The goal of the program is to remove cost as a barrier for eligible commercial patients by assisting with their out-of-pocket costs for DATROWAY. Talk to your doctor to sign up for the program or call DATROWAY at 1-855-DATRO4U (1-855-328-7648).

I cannot afford DATROWAY. What are my options?

There may be options to help you get DATROWAY. DATROWAY can refer you to patient assistance options such as the patient savings program, Patient Assistance Programs (PAP), and independent foundations.

Explore Your Options

My health plan denied coverage for DATROWAY

We have resources to help your doctor file an appeal. Your doctor’s office will need to file an appeal directly with your health plan. Have your doctor visit DATROWAY.com or call 1-855-DATRO4U (1-855-328-7648).

I no longer have or do not have health insurance. What do I do?

If you cannot afford your medicine, you may be able to get help from our Patient Assistance Programs (PAP). PAP can provide DATROWAY for free if you qualify. Eligibility rules apply. Please click here for more information regarding eligibility.

To understand insurance coverage, the following key terms will be helpful.

Brand-name drugs

Drugs marketed under a trade name by the manufacturer that develops and patents them.

Generic drugs

Once the patent (or license) expires on a brand-name drug, a generic chemically equivalent version can be developed and sold at a lower cost.

Premium

Payments made by patient to maintain insurance coverage. This is a monthly payment and varies by insurance plan.

Co-payments (Co-pays)

The set fee patients pay for a covered service every time that service is provided. Co-payments vary depending on the plan. Co-payments do not count toward a deductible but do count toward the annual out-of-pocket maximum for most services. Nearly all plans have co-payments or co-insurance.

Co-insurance

The percentage of the cost the patient pays for a covered service. Co-insurances vary according to the plan and do not apply toward deductibles. However, they do count toward the annual out-of-pocket maximum for most services.

Deductible

The set amount patients must pay each contract year for covered medical services before the insurance plan begins to pay its share. Patients with a deductible will be billed for the full allowable amount for each service that is subject to the deductible.

There are two types of health insurance, private and public. Private, or “commercial” health insurance is insurance you get from your job, or insurance you buy directly from an insurance company or exchange.

Public health insurance is provided by the federal or state government. This includes Medicare, Medicaid, Veterans Health Administration/TRICARE Department of Defense.

Private and public health insurance both include the medical benefit and the pharmacy benefit.

Medical benefit

Typically covers physician and hospital services for things like visits to the doctor, drugs administered by doctors, hospital services and supplies, and some home health services.

Pharmacy benefit

Typically covers prescription drugs taken by mouth, and self-administered injectable prescription drugs that are used at home.

Understanding Medicare

Medicare mainly provides coverage for people who are over the age of 65, blind, or disabled. This program pays for medical services and procedures that have been determined as “reasonable and necessary.” It is important to note that there are various parts of Medicare and benefits vary based on the type of coverage you select.

Medicare Part A
Hospital Insurance

Covers inpatient hospital services and certain follow-up care.

Medicare Part B
Medical Insurance

Covers medically necessary services and supplies. Also covers drugs prescribed and administered by a healthcare provider.

Medicare Part C
Medicare Advantage

Covers part A and part B benefits, and could also include prescription coverage.

Medicare Part D
Medicare Prescription Drug Coverage

These are private insurance plans specifically for prescription drug coverage.

Medicaid

Covers people with low incomes and some disabled people. Funded partly by the federal government and partly by individual states.

Veterans Health Administration/TRICARE DoD (Department of Defense)

Covers people who are or have been in the military, including:

  • Veterans
  • Active-duty service members
  • National Guard and Reserve members
  • Retirees
  • Families of retirees

In order for you to receive DATROWAY4U program offerings, your doctor will complete an enrollment form. If you did not sign this form at your doctor’s office, you can give authorization in 1 of 3 ways:

DATROWAY4U: Patient Access to Treatment

Contact DATROWAY1-855-DATRO4U (1-855-328-7648)

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about DATROWAY?

DATROWAY can cause serious side effects, including:

  • Lung problems that may be severe, life-threatening, or that may lead to death. If you develop lung problems, your healthcare provider may treat you with corticosteroid medicines. Tell your healthcare provider right away if you get any of the following signs and symptoms:
    • cough
    • trouble breathing or shortness of breath
    • fever
    • other new or worsening breathing symptoms such as chest tightness or wheezing
  • Eye problems. Eye problems are common with DATROWAY and can also be severe. Tell your healthcare provider right away if you develop any new or worsening eye problems during treatment with DATROWAY, including dry eyes, eye pain, eye redness, eye swelling, eye irritation, increased tears, feeling like something is in your eyes, discharge from your eyes, eye crusting, sensitivity to light, blurred vision, or vision changes.
    • You should use preservative-free lubricating eye drops at least 4 times a day and as needed.
    • Do not wear contact lenses during treatment with DATROWAY unless your eye specialist tells you to.
    • Your healthcare provider will send you to an eye specialist to check your eyes when you start your treatment with DATROWAY, every three 21-day treatment cycles (about every 9 weeks), at the end of treatment, and as needed for any new or worsening signs and symptoms of eye problems.
  • Mouth ulcers and sores. Mouth ulcers and sores are common with DATROWAY and can also be severe. Tell your healthcare provider right away if you develop mouth pain, swelling, redness, ulcers, or sores during treatment with DATROWAY.
    • Your healthcare provider will prescribe a steroid-containing mouthwash to use 4 times a day and as needed during treatment with DATROWAY.
    • You should hold ice chips or ice water in your mouth during your DATROWAY infusions.

Your healthcare provider will check you for these side effects during your treatment with DATROWAY. Your healthcare provider may reduce your dose, delay treatment, or completely stop treatment with DATROWAY if you have severe side effects.

  • Harm to your unborn baby. Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment with DATROWAY.
    • If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with DATROWAY.
    • Females who are able to become pregnant should use effective birth control (contraception) during treatment with DATROWAY and for 7 months after the last dose.
    • Males who have female partners that are able to become pregnant should use effective birth control (contraception) during treatment with DATROWAY and for 4 months after the last dose.

See “What are the possible side effects of DATROWAY?” for more information about side effects.

What is DATROWAY?

DATROWAY is a prescription medicine used to treat adults who have:

  • non-small cell lung cancer (NSCLC) that has certain mutations in a gene called epidermal growth factor receptor (EGFR):
    • that has spread to areas outside of the lung (locally advanced) or has spread to other parts of the body (metastatic), and
    • who have received prior EGFR-directed medicine and platinum-based chemotherapy.

DATROWAY was FDA approved for this use based on a clinical study that measured how many patients responded and how long they responded. DATROWAY is still being studied to confirm these results.

  • triple-negative breast cancer (TNBC):
    • that cannot be removed by surgery (unresectable) or has spread to other parts of the body (metastatic), and
    • who cannot receive PD-1 or PD-L1 inhibitor therapy.
  • hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer:
    • that cannot be removed by surgery (unresectable) or has spread to other parts of the body (metastatic), and
    • who have received prior endocrine-based therapy and chemotherapy treatment for unresectable or metastatic disease.

It is not known if DATROWAY is safe and effective in children.

Before receiving DATROWAY, tell your healthcare provider about all of your medical conditions, including if you:

  • Have lung or breathing problems.
  • Have eye problems.
  • Use contact lenses.
  • Have kidney problems.
  • Have liver problems.
  • Are breastfeeding or plan to breastfeed. It is not known if DATROWAY passes into your breast milk. Do not breastfeed during treatment with DATROWAY and for 1 month after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive DATROWAY?

  • You will receive DATROWAY into your vein through an intravenous (IV) line by your healthcare provider.
  • DATROWAY is usually given 1 time every three weeks (21-day treatment cycle).
  • You will receive your first infusion over 90 minutes. If you do not have problems with your first infusion, you may receive your next infusions over 30 minutes.
  • You will be monitored for side effects for at least 1 hour after your first 2 infusions. If you do not have problems after your second infusion, you will be monitored for at least 30 minutes after each following infusion.
  • Your healthcare provider will decide how many treatments you need.
  • Your healthcare provider will give you medicines before your infusion to help prevent nausea, vomiting, and infusion-related reactions.
  • Your healthcare provider may slow down or temporarily stop your infusion of DATROWAY if you have an infusion-related reaction, or permanently stop DATROWAY if you have severe infusion reactions, including severe allergic reactions.
  • If you miss a planned dose of DATROWAY, call your healthcare provider right away to schedule an appointment. Do not wait until the next planned treatment cycle.

What are the possible side effects of DATROWAY?

DATROWAY can cause serious side effects, including:

  • See "What is the most important information I should know about DATROWAY?"

The most common side effects of DATROWAY when used in adults with EGFR-mutated NSCLC include:

  • Nausea
  • Hair loss
  • Tiredness
  • Decreased red blood cell counts
  • Decreased white blood cell counts
  • Constipation
  • Increased blood levels of calcium
  • Increased blood levels of liver enzymes
  • Increased levels of enzyme called lactate dehydrogenase in the blood
  • Muscle and joint pain
  • Decreased appetite
  • Rash

The most common side effects of DATROWAY when used in adults with TNBC include:

  • Increased levels of digestive enzyme (amylase) in the blood
  • Nausea
  • Hair loss
  • Decreased red blood cell counts
  • Decreased white blood cell counts
  • Constipation
  • Decreased blood levels of calcium
  • Tiredness
  • Increased blood levels of liver enzymes
  • Dry eye
  • An eye problem called keratitis. See “What is the most important information I should know about DATROWAY?”
  • Decreased protein levels (albumin) in the blood
  • Vomiting
  • Muscle and joint pain
  • Decreased blood levels of sodium
  • Increased blood levels of alkaline phosphatase

The most common side effects of DATROWAY when used in adults with HR-positive HER2-negative breast cancer include:

  • Nausea
  • Tiredness
  • Decreased white blood cell counts
  • Decreased blood levels of calcium
  • Hair loss
  • Decreased red blood cell counts
  • Constipation
  • Dry eye
  • Vomiting
  • Increased blood levels of liver enzymes
  • An eye problem called keratitis
  • Increased blood levels of alkaline phosphatase

DATROWAY may cause fertility problems in males and females, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertility.

These are not all of the possible side effects of DATROWAY. Call your healthcare provider for medical advice about side effects. You may report side effects to Daiichi Sankyo at 1-877-437-7763 or to FDA at 1-800-FDA-1088.

Please see Prescribing Information and Medication Guide for additional Important Safety Information.